GeoVax Labs, Inc. (GOVXW)

Market Cap	15.50M
Revenue (ttm)	5.59M
Net Income (ttm)	-24.50M
Shares Out	11.95M
EPS (ttm)	-3.23
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.0141 - 0.6500
Beta	3.71
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 5, 2025

About GOVXW

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It also developing GEO-CM04S1, a vacc...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 17
• Stock Exchange: NASDAQ
• Ticker Symbol: GOVXW
• Website: https://www.geovax.com